Incorporating sTILs Into PREDICT Substantially Improves the Model’s Ability to Distinguish High- and Low-Risk Patients with TNBC By Ogkologos - May 5, 2026 150 0 Facebook Twitter Google+ Pinterest WhatsApp Building the PREDICT_sTILs prognostication model Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Serplulimab Benefit of Adjuvant Chemotherapy in Patients with ctDNA-positive Resected Stage II Colon Cancer FDA Approves Palbociclib with Trastuzumab, With or Without Pertuzumab, and Endocrine Therapy for the Maintenance Treatment of HR-positive, HER2-positive LA/MBC MOST POPULAR 10 Ways to Provide Support During Breast Cancer Awareness Month September 27, 2019 Shannon’s Law Requires NY Insurance Companies to Cover Mammograms for Ages... August 9, 2019 Happy Holidays from the OncoLink Team December 7, 2023 Woman With Double Mastectomy Invents Breastfeeding Simulator For Breast Cancer Survivors November 15, 2019 Load more HOT NEWS FDA Grants Accelerated Approval to Zanidatamab-hrii for Patients with Previously Treated... Nivolumab Demonstrates Clinical Benefits in a Statistically Evaluable Number of Patients... Cancer Drug Lynparza Found to Lower Risk of Death and Recurrence... A Daily Survival Kit for Serious Illness
